• Tue. Jul 2nd, 2024

Exploring Medicare Coverage for GLP-1s in the Context of the Presidential Debate

By

Jun 28, 2024

Medicare may soon start covering weight loss drugs like Zepbound and Wegovy, a new proposal in Washington suggests. These drugs could play a significant role in addressing the obesity epidemic in the country. Additionally, health care issues are expected to be major points of discussion in the upcoming election, with policies around coverage, access, and affordability taking center stage. The first presidential debate is anticipated to provide insight into each candidate’s stance on these critical issues.

In a recent episode of “The Readout LOUD” podcast, STAT chief Washington correspondent Rachel Cohrs Zhang discusses the proposal for obesity drug coverage and offers insights into what we can expect from the upcoming debate. Meanwhile, health tech reporter Brittany Trang co-hosts the episode, where discussions around AI for drug development, updates on the H5N1 bird flu outbreak, developments in the GLP-1 field, and other news in the life sciences are featured.

To delve deeper into the obesity coverage proposal and stay informed on important health care policies in the election cycle, listeners can access additional resources provided in the episode. Information on the bird flu response, Basecamp’s use of AI in enzyme design, Brittany’s Q&A with Cellarity, and challenges facing Grail are also covered in the podcast. Listeners are encouraged to subscribe to “The Readout LOUD” on various platforms such as Apple Podcasts, Spotify, Stitcher, TuneIn, or any preferred podcast platform to stay updated on the latest developments in the health care and life sciences sectors.

By

Leave a Reply